China Money Network
Login
Join

Temasek Leads $70M Series C Round In Chinese Biotech Firm Abbisko

  • March 25, 2020 — 19:49 CST

This Data Is Locked!

This area is available only to Subscribers.

Abbisko Therapeutics, a Chinese oncology focused biopharmaceutical company, recently announced the completion of a US$70 million Series C financing, led by Temasek, joined by existing... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Join

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?

Login
Related Topics:

Related Data: